Medical News

RSS

OHSU acquires BSD-500 Hyperthermia System

BSD Medical Corporation is pleased to announce that Oregon Health & Science University has acquired a BSD-500 Hyperthermia System. OHSU is a leading university that provides world-class treatment for the most complex health care needs. OHSU has been ranked in U.S. News & World Report's annual rankings as one of America's Best Hospitals for 15 consecutive years and has been recognized in the medical specialties of cancer and endocrinology.

2 Aug 2010

The NoliWhite Group launches innovative process to integrate iPad on hospital construction sites

The NoliWhite Group, Brentwood-based healthcare facility developers, launched an innovative process that will incorporate the use of Apple's iPad on hospital and other healthcare-related construction sites, officials announced today. The initiative, Project Information Integration, or PI2, is being piloted on the construction of John D. Archbold Memorial Hospital's new North Tower in Thomasville, GA.

2 Aug 2010

Today's OpEds: Medicaid and the safety net; Health reform law's impact on long-term care and health costs

Late last week, the federal government provided a road map [for how to help those with little access to care] by extending an existing agreement that allows up to $25 million in Medicaid payments to hospitals to be diverted instead to clinics that serve the uninsured. You might think that would be a hard sell for hospitals; after all, they're experiencing sharp growth in the number of uninsured patients they serve. But St. Louis-area hospitals willingly have been sharing those payments with clinics for a decade. Without them, there simply wouldn't be a health care safety net to meet the region's needs (8/1).

2 Aug 2010

Taligen Therapeutics to highlight three pipeline candidates at XXIII ICW

Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that preclinical data on three of its pipeline candidates will be highlighted at the XXIII International Complement Workshop taking place August 1-5, 2010, in New York City.

2 Aug 2010

Take Care Health Systems applauds US Senate for declaration of National Convenient Care Clinic Week

Take Care Health Systems, a wholly-owned subsidiary of Walgreens and the nation's largest and most comprehensive manager of convenient care clinics and worksite health and wellness centers, today praised the US Senate for its declaration of August 2-8 as "National Convenient Care Clinic Week". The resolution was introduced by Senator Daniel Inouye (D-HI) and Senator Thad Cochran (R-MS) and passed the Senate by unanimous consent.

2 Aug 2010

Research findings could lead to new drugs that reduce severity of blood infections leading to sepsis

Scientists have made an important discovery that could lead to new drugs that reduce the severity of blood infections leading to sepsis. Research presented in the August 2010 issue of Journal of Leukocyte Biology shows how interfering with the function of the cell membrane protein called "Programmed Death 1" (PD-1) improves survival in a clinically relevant model of severe infection.

2 Aug 2010

WellDoc DiabetesManager System receives FDA clearance

WellDoc, a healthcare company that develops technology solutions to improve chronic disease management outcomes and reduce healthcare costs, today announced that it has received United States Food and Drug Administration 510(k) clearance to market the WellDoc DiabetesManager System to healthcare providers and their adult patients with type 2 diabetes.

2 Aug 2010

BGU Professor awarded grant to develop target-specific, anti-cancer drugs

Ben-Gurion University of the Negev Professor Varda Shoshan-Barmatz has been awarded a three-year, $600,000 grant from the U.S. Leukemia & Lymphoma Society to develop target-specific, anti-cancer drugs.

2 Aug 2010

KHN column: Why the health reform repealers are wrong

"The effort to repeal health care reform, all in one fell swoop, seems to be stalling. Instead, the opponents of reform are trying to dismantle it piece by piece. The latest effort came last week, when a group of Republicans in the Senate proposed abolishing the Independent Payment Advisory Board. And therein lies a lesson about the future of American health care--and the two different shapes it could take" (8/2).

2 Aug 2010

Cardioxyl Pharmaceuticals achieves positive results in first clinical study of CXL-1020 for ADHF

Cardioxyl Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing novel therapeutic agents for the treatment of cardiovascular disease, today announced that it has achieved positive safety and tolerability results in the first clinical study of its lead drug candidate, CXL-1020, for the treatment of patients with acute decompensated heart failure. Each year in the United States, more than one million patients are hospitalized with acute heart failure.

2 Aug 2010

Thymosin beta 4 is essential to healthy heart development, embryonic survival: Research

RegeneRx Biopharmaceuticals, Inc. today announced that a research team from the Molecular Medicine Unit at UCL-Institute of Child Health in London reported preclinical findings that Thymosin beta 4, is essential to healthy heart development and embryonic survival.

2 Aug 2010

StatRad introduces Stat360 teleradiology solution

StatRad, a leading provider of premier teleradiology services, announces today the introduction of Stat360, the most comprehensive teleradiology solution on the market. Stat360 combines traditional teleradiology services with PACS and live support from virtual radiology assistants with radiologist productivity in mind.

2 Aug 2010

U.S. gastroenterologists prescribe Abbott's Humira off-label for treating ulcerative colitis: Report

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 63 percent of surveyed U.S. gastroenterologists prescribe Abbott's Humira off-label for the treatment of ulcerative colitis. According to the new report entitled Treatment Algorithms in Ulcerative Colitis, surveyed gastroenterologists most often prescribe Humira for ulcerative colitis for patients with loss of response, intolerance or no response to Centocor Ortho Biotech's Remicade.

2 Aug 2010

Repligen receives three additional grants to develop HDAC inhibitors for neurodegenerative diseases

Repligen Corporation today announced that the Company has received three additional grants to support its research program to develop HDAC inhibitors for neurodegenerative diseases. Repligen has received $436,000 in research funding to support the ongoing development of histone deacetylase inhibitors for Friedreich's ataxia.

2 Aug 2010

Osteologix grants Servier Research Group exclusive license to develop, commercialize NB S101

Osteologix, Inc. through its wholly owned Irish subsidiary Osteologix Limited and the Servier Research Group, the leading French independent pharmaceutical company, today announced that Osteologix has granted Servier an exclusive royalty bearing license to develop and commercialize NB S101 (strontium malonate) to treat post menopausal osteoporosis, other bone and joint disorders and dental indications worldwide, except in the U.S. NB S101 is an innovative molecule acting on both bone formation and bone resorption.

2 Aug 2010

NFF awarded $1M to improve financial health of local community organizations

Nonprofit Finance Fund has been awarded $1 million from Trinity Health in Novi, Michigan, to improve the access to capital for Michigan nonprofits. NFF will use this investment to provide loans to nonprofit organizations in southeast Michigan, the home of seven of Trinity's 47 hospitals. The funds will be used to finance community facilities projects and organizations working in low-wealth communities, providing working capital for construction of buildings, facilities improvements, and equipment purchases.

2 Aug 2010

MannKind second-quarter total operating expenses decrease to $16.0 million

MannKind Corporation today reported financial results for the second quarter ended June 30, 2010.

2 Aug 2010

Keane Optimum 3.1 receives Preliminary ARRA IFR Stage 1 certification

Keane, Inc., a U.S.-based IT services and healthcare information technology firm, today announced Keane OptimumTM 3.1 has been inspected by the Certification Commission for Health Information Technology and is certified EHR technology, IFR Stage 1 as part of the organization's Preliminary American Recovery and Reinvestment Act of 2009 certification program.

2 Aug 2010

Inergetics receives initial purchase order from New Marketlink for Resurgex Select

Inergetics, Inc., a leader in targeted product development for the Clinical Nutrition and Sports Supplement Markets, today announced that the Company has received a $112,500 purchase order for Resurgex Select from New Marketlink Pharmaceutical Corporation "New Marketlink."

2 Aug 2010

Hasco Medical signs agreement to distribute Bell-Horn Orthopedic products

Hasco Medical, Inc., www.mysouthernmed.com, a managed healthcare provider that serves patients in Alabama, Florida, and Mississippi, today announced the Company will begin national distribution of the complete line of Bell-Horn Orthopedic products, www.bellhorn.com.

2 Aug 2010

Medical News

OHSU acquires BSD-500 Hyperthermia System

The NoliWhite Group launches innovative process to integrate iPad on hospital construction sites

Today's OpEds: Medicaid and the safety net; Health reform law's impact on long-term care and health costs

Taligen Therapeutics to highlight three pipeline candidates at XXIII ICW

Take Care Health Systems applauds US Senate for declaration of National Convenient Care Clinic Week

Research findings could lead to new drugs that reduce severity of blood infections leading to sepsis

WellDoc DiabetesManager System receives FDA clearance

BGU Professor awarded grant to develop target-specific, anti-cancer drugs

KHN column: Why the health reform repealers are wrong

Cardioxyl Pharmaceuticals achieves positive results in first clinical study of CXL-1020 for ADHF

Thymosin beta 4 is essential to healthy heart development, embryonic survival: Research

StatRad introduces Stat360 teleradiology solution

U.S. gastroenterologists prescribe Abbott's Humira off-label for treating ulcerative colitis: Report

Repligen receives three additional grants to develop HDAC inhibitors for neurodegenerative diseases

Osteologix grants Servier Research Group exclusive license to develop, commercialize NB S101

NFF awarded $1M to improve financial health of local community organizations

MannKind second-quarter total operating expenses decrease to $16.0 million

Keane Optimum 3.1 receives Preliminary ARRA IFR Stage 1 certification

Inergetics receives initial purchase order from New Marketlink for Resurgex Select

Hasco Medical signs agreement to distribute Bell-Horn Orthopedic products

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Latest News